Skip to main content
Article
Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)
Diabetes (2018)
  • Katherine R. Tuttle, Spokane, WA, Indianapolis, IN, Cape Town, South Africa, Albany, NY
  • Mark Lakshmanan, Spokane, WA, Indianapolis, IN, Cape Town, South Africa, Albany, NY
  • Brian L. Rayner, Spokane, WA, Indianapolis, IN, Cape Town, South Africa, Albany, NY
  • Robert S. Busch, Spokane, WA, Indianapolis, IN, Cape Town, South Africa, Albany, NY
  • Alan G. Zimmermann, Spokane, WA, Indianapolis, IN, Cape Town, South Africa, Albany, NY
  • Brad Woodward, Spokane, WA, Indianapolis, IN, Cape Town, South Africa, Albany, NY
  • Fady T. Botros, Spokane, WA, Indianapolis, IN, Cape Town, South Africa, Albany, NY
Publication Date
May 1, 2018
DOI
10.2337/db18-1066-p
Citation Information
Katherine R. Tuttle, Mark Lakshmanan, Brian L. Rayner, Robert S. Busch, et al.. "Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)" Diabetes Vol. 67 (2018)
Available at: http://works.bepress.com/katherine-tuttle/176/